Your browser doesn't support javascript.
loading
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors.
Gerritse, Sophie L; Labots, Mariette; Ter Heine, Rob; Dekker, Henk; Poel, Dennis; Tauriello, Daniele V F; Nagtegaal, Iris D; Van Den Hombergh, Erik; Van Erp, Nielka; Verheul, Henk M W.
Afiliação
  • Gerritse SL; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
  • Labots M; Department of Medical Oncology, Cancer Institute, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Ter Heine R; Department of Medical Oncology, Cancer Center Amsterdam, Location VUmc, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands.
  • Dekker H; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
  • Poel D; Department of Medical Oncology, Cancer Center Amsterdam, Location VUmc, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands.
  • Tauriello DVF; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
  • Nagtegaal ID; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
  • Van Den Hombergh E; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
  • Van Erp N; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
  • Verheul HMW; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Cancers (Basel) ; 14(24)2022 12 09.
Article em En | MEDLINE | ID: mdl-36551546

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda